"... Led, we are now down to 13 trading days left, up to and including my projected release date (chosen using the current flowing average periods for all previous reports) for the seventh DSMB report, Monday, June 11th."

ERA-EDTA starts in a couple days (2 presentations + symposium) and BIO International presentation June 6th....a few days before your June 11th projection. Hopefully some kind of substantial news release and/or corporate update on or before June 6th. Hey, they might even update their April fact sheet on their website before the end of May to reflect the conference(s) they've already attended and presented at but never announced. Resverlogix may or may not be unblinded (*), but no reason to keep investors in the dark on everything!

BearDownAZ

(*) I wish I could say with more certaintly that Resverlogix is still blinded as they have claimed to be throughout the trial (as recent as Feb 26th, 2018), but Resverlogix has declined to provide clarification when asked and therefore the blinded status of the trial is now ambiguous.